Headlines about Univar (NYSE:UNVR) have trended somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Univar earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned media stories about the basic materials company an impact score of 45.2399014605358 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
These are some of the media stories that may have impacted Accern’s scoring:
- Global Mosquito Control Market 2018 Review- Univar, Valent BioSciences, BASF, Summit Chemical (AMVAC) and … (satprnews.com)
- Global Mosquito Control Market 2018 – BASF, Summit Chemical (AMVAC), Univar, UPL, Kadant GranTek, Babolna-Bio (businessservices24.com)
- Univar (UNVR) Rating Increased to B- at TheStreet (americanbankingnews.com)
- Analysts Insights on Univar Inc (UNVR) (emnnews.com)
- Univar Inc. (NYSE:UNVR): Stochastic Analysis (oracleexaminer.com)
Several analysts have recently weighed in on the stock. TheStreet upgraded shares of Univar from a “c+” rating to a “b-” rating in a research report on Monday. SunTrust Banks upgraded shares of Univar from a “hold” rating to a “buy” rating in a research report on Tuesday, February 13th. Zacks Investment Research upgraded shares of Univar from a “hold” rating to a “buy” rating and set a $31.00 target price on the stock in a research report on Wednesday, February 28th. ValuEngine lowered shares of Univar from a “hold” rating to a “sell” rating in a research report on Monday. Finally, Deutsche Bank set a $34.00 price target on shares of Univar and gave the company a “hold” rating in a research report on Wednesday, March 7th. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $32.67.
Univar (NYSE:UNVR) last released its quarterly earnings results on Wednesday, February 28th. The basic materials company reported $0.34 EPS for the quarter, beating the Zacks’ consensus estimate of $0.25 by $0.09. The firm had revenue of $1.96 billion for the quarter, compared to analyst estimates of $1.85 billion. Univar had a net margin of 1.45% and a return on equity of 17.25%. The company’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.25 earnings per share. research analysts expect that Univar will post 1.72 EPS for the current fiscal year.
In other news, insider Dahlia Investments Pte. Ltd. sold 2,015 shares of the company’s stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $31.12, for a total transaction of $62,706.80. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders have sold 93,587 shares of company stock worth $2,914,052 over the last quarter. 1.82% of the stock is owned by company insiders.
Univar Inc is a distributor of commodity and specialty chemicals. The Company operates through four segments: Univar USA (USA); Univar Canada (Canada); Univar Europe and the Middle East and Africa (EMEA), and Rest of World. The Company’s USA segment supplies a range of commodity and specialty chemicals, as well as services to a range of end markets, including manufacturing and industrial production sectors in the United States.
Receive News & Ratings for Univar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Univar and related companies with MarketBeat.com's FREE daily email newsletter.